Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfonso Romano

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
European Journal of Pediatrics|August 16, 2012
Diagnosis delay in West syndrome: misdiagnosis and consequencesStéphane Auvin, Adam L Hartman, Béatrice Desnous, et al.
European Journal of Medical Genetics|April 3, 2022
Mild neurological phenotype in a family carrying a novel N-terminal null GRIN2A variantMargherita Lucia De Bernardi, Agnese Di Stazio, Alfonso Romano, et al.
American Journal of Medical Genetics. Part A|August 21, 2012
De novo 13q12.3-q14.11 deletion involving BRCA2 gene in a patient with developmental delay, elevated IgM levels, transient ataxia, and cerebellar hypoplasia, mimicking an A-T like phenotypeEmilia Cirillo, Rosa Romano, Alfonso Romano, et al.
The Journal of Pediatrics|May 6, 2004
Brain damage in glycogen storage disease type IDaniela Melis, Giancarlo Parenti, Roberto Della Casa, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 28, 2022
Electroencephalographic findings in ATRX syndrome: A new case series and review of literatureSalvatore Aiello, Maria Margherita Mancardi, Alfonso Romano, et al.
Molecular Genetics & Genomic Medicine|August 12, 2020
Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experienceRita Fischetto, Valentina Palladino, Maria M Mancardi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2014
A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapyGiancarlo Parenti, Simona Fecarotta, Giancarlo la Marca, et al.
Orphanet Journal of Rare Diseases|April 19, 2015
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type CSimona Fecarotta, Alfonso Romano, Roberto Della Casa, et al.
Journal of Medical Genetics|February 14, 2023
Recurrent, founder and hypomorphic variants contribute to the genetic landscape of Joubert syndromeValentina Serpieri, Giulia Mortarini, Hailey Loucks, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Journal of Pediatrics|August 16, 2012
Diagnosis delay in West syndrome: misdiagnosis and consequencesStéphane Auvin, Adam L Hartman, Béatrice Desnous, et al.
European Journal of Medical Genetics|April 3, 2022
Mild neurological phenotype in a family carrying a novel N-terminal null GRIN2A variantMargherita Lucia De Bernardi, Agnese Di Stazio, Alfonso Romano, et al.
American Journal of Medical Genetics. Part A|August 21, 2012
De novo 13q12.3-q14.11 deletion involving BRCA2 gene in a patient with developmental delay, elevated IgM levels, transient ataxia, and cerebellar hypoplasia, mimicking an A-T like phenotypeEmilia Cirillo, Rosa Romano, Alfonso Romano, et al.
The Journal of Pediatrics|May 6, 2004
Brain damage in glycogen storage disease type IDaniela Melis, Giancarlo Parenti, Roberto Della Casa, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 28, 2022
Electroencephalographic findings in ATRX syndrome: A new case series and review of literatureSalvatore Aiello, Maria Margherita Mancardi, Alfonso Romano, et al.
Molecular Genetics & Genomic Medicine|August 12, 2020
Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experienceRita Fischetto, Valentina Palladino, Maria M Mancardi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2014
A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapyGiancarlo Parenti, Simona Fecarotta, Giancarlo la Marca, et al.
Orphanet Journal of Rare Diseases|April 19, 2015
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type CSimona Fecarotta, Alfonso Romano, Roberto Della Casa, et al.
Journal of Medical Genetics|February 14, 2023
Recurrent, founder and hypomorphic variants contribute to the genetic landscape of Joubert syndromeValentina Serpieri, Giulia Mortarini, Hailey Loucks, et al.
Pageof 4